Skip to main content
SpringerLink
Log in

Research Contributions of Magnetic Resonance Spectroscopy in Psychopathology

  • Chapter
  • First Online:
Psychiatry and Neuroscience Update

  • 1124 Accesses

Abstract

In recent years, within the neuroscience community, there has been a growing interest in advanced neuroimaging techniques in order to better understand psychopathologic disorders. One of the fundamental imaging techniques is called Magnetic Resonance Spectroscopy (MRS), which is based on the chemical shift property of the atom nuclei when a magnetic field is applied. This technique offers invaluable information about living tissues and is particularly helpful in the diagnosis and prognosis of diseases affecting the central nervous system. Numerous studies have used Magnetic Resonance Imaging (MRI) to assess structural abnormalities of the brain associated with psychiatric disorders; and there has been an increased use of MR spectroscopy as it allows characterizing of the metabolic or chemical abnormalities of tissues in some of these specific entities. In this chapter, we will discuss our most relevant clinical and applied research work in the field of psychopathology using hydrogen Magnetic Resonance Spectroscopy, including autism spectrum disorders, attention-deficit/hyperactivity disorder, delayed psychomotor development, mild cognitive impairment and Alzheimer’s disease, Parkinson’s disease, somatoform disorders, and fibromyalgia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bloch F. Nuclear induction. Phys Rev. 1946;70:460–74.

    Article  CAS  Google Scholar 

  2. Purcell EU, Torrey HC, Pound RV. Resonance absorption by nuclear magnetic moments in a solid. Phys Rev. 1946;69:37–8.

    Article  CAS  Google Scholar 

  3. Lauterbur PC. Image formation by induced local interactions: examples employing nuclear magnetic resonance. Nature. 1973;242:190–1.

    Article  CAS  Google Scholar 

  4. Mansfield P, Grannell PK. Solid state physics. J Phys. 1973;6:L422–6.

    CAS  Google Scholar 

  5. Fayed N, Olmos S, Morales H, Modrego PJ. Physical basis of magnetic resonance spectroscopy and its application to central nervous system diseases. Am J Appl Sci. 2006;3:1836–45.

    Article  CAS  Google Scholar 

  6. Stark DD, Bradley WG Jr. Resonancia Magnética. Tercera Edición. Mosby. Ediciones Harcourt, capitulo 9; Gerald B. Matson y Michael W. Weiner; 2000;181–214.

    Google Scholar 

  7. Maheshwari S, Fatterpeaker G, Castillo M, Murkherji SK. Proton MR spectroscopy of the brain. Semin Ultrasound CT MR. 2000;21:434–51.

    Article  CAS  PubMed  Google Scholar 

  8. Bonavita S, Di Salle F, Tedeschi G. Proton MRS in neurological disease. Eur J Radiol. 1999;30:125–31.

    Article  CAS  PubMed  Google Scholar 

  9. Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol. 1996;17:1–15.

    CAS  PubMed  Google Scholar 

  10. Sauter R, Schneider M, Wicklow K, Kolem H. Localized 1H MRS of the human brain: single-voxel versus CSI techniques. J Magn Reson Imaging. 1991;1:241.

    Article  Google Scholar 

  11. Hsu YY, Chang C, Chang CN, Chu NS, Lim KE, Hsu JC. Proton MR spectroscopy in patients with complex partial seizures: single-voxel spectroscopy versus chemical-shift imaging. AJNR Am J Neuroradiol. 1999;20:643–51.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Hsu YY, Chen MC, Lim KE, Chang C. Reproducibility of hippocampal single-voxel proton MR spectroscopy and chemical shift imaging. AJR Am J Roentgenol. 2001;176:529–36.

    Article  CAS  PubMed  Google Scholar 

  13. Law M. MR spectroscopy of brain tumors. Top Magn Reson Imaging. 2004;15:291–313.

    Article  PubMed  Google Scholar 

  14. Fayed N, Modrego PJ, Medrano J. Comparative test-retest reliability of metabolite values assessed with magnetic resonance spectroscopy of the brain. The LCModel versus the manufacturer software. Neurol Res. 2009;31:472–7.

    Article  PubMed  Google Scholar 

  15. Antuono PG, Jones JL, Wang Y, et al. Decreased glutamate + glutamine in Alzheimer’s disease detected in vivo with (1) H-MRS at 0.5 T. Neurology. 2002;56:737–42.

    Article  Google Scholar 

  16. Fayed N, Modrego PJ, Rojas-Salinas G, et al. Glutamate is decreased in Alzheimer’s disease. A magnetic resonance spectroscopy study. Am J Alzheimers Dis Other Dement. 2011;26:450–6.

    Article  Google Scholar 

  17. Hattori N, Abe K, Sakoda S, et al. Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer’s disease. Neuroreport. 2002;13:183–6.

    Article  CAS  PubMed  Google Scholar 

  18. Rupsingh R, Borrie M, Smith M, et al. Reduced hippocampal glutamate in Alzheimer disease. Neurobiol Aging. 2009;32:802–10.

    Article  PubMed  CAS  Google Scholar 

  19. Resnick SM, Pham DL, Kraut MA, et al. Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J Neurosci. 2003;23:3295–301.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Fayed N, Modrego PJ. Comparative study of cerebral white matter in autism and attention-deficit/hyperactivity disorder by means of magnetic resonance spectroscopy. Acad Radiol. 2005;12:566–9.

    Article  PubMed  Google Scholar 

  21. Fayed N, Modrego PJ, Castillo J, Dávila J. Evidence of brain dysfunction in attention deficit-hyperactivity disorder: a controlled study with proton magnetic resonance spectroscopy. Acad Radiol. 2007;14:1029–35.

    Article  PubMed  Google Scholar 

  22. Ross B, Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q. 1994;10:191–247.

    CAS  PubMed  Google Scholar 

  23. Bonavita S, Di Salle F, Tedeschi G. Proton MRS in neurological disorders. Eur J Radiol. 1999;30:125–31.

    Article  CAS  PubMed  Google Scholar 

  24. Otsuka H, Harada M, Mori K, Hisaoka S, Nishitani H. Brain metabolites in the hippocampus-amygdala region and cerebellum in autism: an 1H-MR spectroscopy study. Neuroradiology. 1999;41:517–9.

    Article  CAS  PubMed  Google Scholar 

  25. Levitt JG, O'Neill J, Blanton RE, Smalley S, Fadale D, McCracken JT, et al. Proton magnetic resonance spectroscopic imaging of the brain in childhood autism. Biol Psychiatry. 2003;54:1355–66.

    Article  CAS  PubMed  Google Scholar 

  26. Simeonsson RJ, Sharp MC. Developmental delays. In: Hoekelman RA, Friedman SB, Nelson NM, et al., editors. Primary pediatric care. St. Louis: Mosby-Year Book; 1992. p. 767–870.

    Google Scholar 

  27. Schaefer GB, Bodensteiner JB. Radiological findings in developmental delay. Semin Pediatr Neurol. 1998;5:33–8.

    Article  CAS  PubMed  Google Scholar 

  28. Shevell MI. The evaluation of the child with a global developmental delay. Semin Pediatr Neurol. 1998;5:21–6.

    Article  CAS  PubMed  Google Scholar 

  29. Fayed N, Morales H, Modrego PJ, Muñoz-Mingarro J. White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination? Acad Radiol. 2006;13:229–35.

    Article  PubMed  Google Scholar 

  30. Modrego PJ, Fayed N, Pina MA. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy. Am J Psychiatr. 2005;162:667–75.

    Article  PubMed  Google Scholar 

  31. Modrego PJ, Fayed N, Sarasa M. Magnetic resonance spectroscopy in the prediction of early conversion from amnestic mild cognitive impairment to dementia: a prospective cohort study. BMJ Open. 2011;1:e000007.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Fayed N, Dávila J, Oliveros A, Castillo J, Medrano JJ. Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia. Acad Radiol. 2008;15:1089–98.

    Article  PubMed  Google Scholar 

  33. Fayed N, Dávila J, Oliveros A, Medrano J, Castillo J. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment. Neurol Res. 2010;32:157–65.

    Article  CAS  PubMed  Google Scholar 

  34. Modrego PJ, Pina MA, Fayed N, Díaz M. Changes in metabolite ratios after treatment with rivastigmine in Alzheimer’s disease: a nonrandomised controlled trial with magnetic resonance spectroscopy. CNS Drugs. 2006;20:867–77.

    Article  CAS  PubMed  Google Scholar 

  35. Modrego PJ, Fayed N, Errea JM, Rios C, Pina MA, Sarasa M. Memantine versus donepezil in mild to moderate Alzheimer’s disease: a randomized trial with magnetic resonance spectroscopy. Eur J Neurol. 2009;17:405–12.

    Article  PubMed  Google Scholar 

  36. Chételat G. Multimodal neuroimaging in Alzheimer’s disease: early diagnosis, physiopathological mechanisms, and impact of lifestyle. J Alzheimers Dis. 2018;64:S199–211.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Tabatabaei-Jafari H, Walsh E, Shaw ME, Cherbuin N. For the Alzheimer’s Disease Neuroimaging Initiative (ADNI), a simple and clinically relevant combination of neuroimaging and functional indexes for the identification of those at highest risk of Alzheimer’s disease. Neurobiol Aging. 2018; https://doi.org/10.1016/j.neurobiolaging.2018.05.006.

  38. Holshouser BA, Komu M, Moller HE. Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson’s disease: a multicenter pilot study. Magn Reson Med. 1995;33:589–94.

    Article  CAS  PubMed  Google Scholar 

  39. O’Neil J, Schuff N, Marks WJ Jr, Feiwell R, Aminoff MJ, Weiner MW. Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson’s disease. Movement Disord. 2002;17:917–27.

    Article  Google Scholar 

  40. Oz G, Terpstra M, Tkác I, Aia P, Lowary J, Tuite PJ, et al. Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations. Magn Reson Med. 2006;55:296–301.

    Article  CAS  PubMed  Google Scholar 

  41. Modrego PJ, Fayed N, Artal J, Olmos S. Correlation of findings in advanced MRI techniques with global severity scales in patients with Parkinson disease. Acad Radiol. 2011;18:235–41.

    Article  PubMed  Google Scholar 

  42. Fayed N, Garcia-Campayo J, Magallón R, Andrés-Bergareche H, Luciano JV, Andres E, et al. Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate. Arthritis Res Ther. 2010;12:R134.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  43. Córdoba J, Sanpedro F, Alonso J, Rovira A. 1 H magnetic resonance in the study of hepatic encephalopathy in humans. Metab Brain Dis. 2002;17:415–29.

    Article  PubMed  Google Scholar 

  44. Häussinger D, Kircheis G, Fischer R, Schliess F, vom Dahl S. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J Hepatol. 2000;32:1035–8.

    Article  PubMed  Google Scholar 

  45. Fayed N, García-Martí G, Sanz-Requena R, Martí-Bonmatí L, Garcia-Campallo J. Difference in regional brain volume between fibromyalgia patients and long-term meditators. Actas Esp Psiquiatr. 2017;45:268–76.

    PubMed  Google Scholar 

  46. Fayed N, Andres E, Rojas G, Moreno S, Serrano-Blanco A, Roca M, et al. Brain dysfunction in fibromyalgia and somatization disorder using proton magnetic resonance spectroscopy: a controlled study. Acta Psychiatr Scand. 2011;126:115–25.

    Article  PubMed  CAS  Google Scholar 

  47. Fayed N, Andrés E, Viguera L, Modrego P, Garcia-Campayo J. Higher glutamate+glutamine and reduction of N-acetyl-aspartate in posterior cingulate according to age range in patients with cognitive impairment and/or pain. Acad Radiol. 2014;21:1211–7.

    Article  PubMed  Google Scholar 

  48. Flores EM, Cappelari SE, Pereira P, Picada JN. Effects of memantine, a non-competitive N-methyl-D-aspartate receptor antagonist, on genomic stability. Basic Clin Pharmacol Toxicol. 2011;109:413–7.

    Article  CAS  PubMed  Google Scholar 

  49. Olivan-Blázquez B, Herrera-Mercadal P, Puebla-Guedea M, Pérez-Yus M-C, Andrés E, Fayed N, del Hoyo YL, Magallon R, Roca M, Garcia-Campayo J. Efficacy of memantine in the treatment of fibromyalgia: a dobled-blind randomized controlled trial with 6- month follow-up. Pain. 2014;155:2517–25.

    Article  PubMed  CAS  Google Scholar 

  50. Fayed N, Olivan-Blázquez B, Herrera-Mercadal P, Puebla-Guedea M, Pérez-Yus M-C, Andrés E, del Hoyo YL, Magallon R, Viguera L, Garcia-Campayo J. Changes in metabolites after treatment with memantine in fibromyalgia. A double-blind randomized controlled trial with magnetic resonance spectroscopy with 6-month follow-up. CNS Neurosci Ther. 2014;20:999–1007.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Section of Neuroradiology, Quirónsalud Hospital, Zaragoza, Spain

    Nicolás Miguel Fayed

  2. Section of Neuroradiology, Department of Radiology, University of Ottawa, Ottawa, ON, Canada

    Carlos Torres

  3. Section of Neuroradiology, Department of Radiology, University of Cincinnati Medical Center, Cincinnati, OH, USA

    Humberto Morales

  4. Department of Radiology, Quirónsalud Hospital, Zaragoza, Spain

    Luisa F. Ángel Ríos

  5. Department of Hematology, Miguel Servet Hospital, Zaragoza, Spain

    Alicia Fayed Coca

Authors
  1. Nicolás Miguel Fayed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlos Torres
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Humberto Morales
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Luisa F. Ángel Ríos
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alicia Fayed Coca
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicolás Miguel Fayed .

Editor information

Editors and Affiliations

  1. Laboratory of Neurosciences and Experimental Psychology Latin American Technological Corporation Foundation (FUCOTEL) Cathedra of Psychopathology, Catholic University of Argentina Area of Pharmacology Department of Pathology, National University of Cuyo CONICET, Guaymallén, Mendoza, Argentina

    Pascual Ángel Gargiulo

  2. National Academy of Medicine, Buenos Aires, Argentina

    Humberto Luis Mesones Arroyo

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Fayed, N.M., Torres, C., Morales, H., Ángel Ríos, L.F., Fayed Coca, A. (2021). Research Contributions of Magnetic Resonance Spectroscopy in Psychopathology. In: Gargiulo, P.Á., Mesones Arroyo, H.L. (eds) Psychiatry and Neuroscience Update. Springer, Cham. https://doi.org/10.1007/978-3-030-61721-9_45

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-61721-9_45

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-61720-2

  • Online ISBN: 978-3-030-61721-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation